Policy / Pricing US pharma tariffs of up to 100% finalised by Trump PharmaphorumTrump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.Policy / PricingRead full story pharminent April 3, 2026 (Last updated: April 3, 2026) Pharmaphorum Trump signs his pharma tariffs executive order, which won’t affect most large pharma groups but could deal a hefty blow to smaller companies. Policy / PricingRead full story Post navigation Previous: Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the BlowNext: BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
